As of 2025-07-06, the Fair Value of Transgene Biotek Ltd (526139.BO) is -2.23 INR. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 4.85 INR, the upside of Transgene Biotek Ltd is -146.00%.
With the market price of 4.85 INR and our fair value calculation, Transgene Biotek Ltd (526139.BO) is not a good investment. Investing in 526139.BO stocks now will result in a potential loss of 146.00%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 5Y Avg | |
| Net income | -104.35 | -104.02 | -60.09 | -6.55 | -6.76 | -56.35 |
| YoY growth | 4.81% | 0.31% | 42.24% | 89.09% | -3.14% | 26.66% |
| Market Cap (mil) | 367.48 |
| P/E | |
| Forward P/E |
| EPS | -0.09 |
| Avg earnings growth rate | 26.66% |
| TTM earnings | -6.76 |